Ruxience 100 mg/10mL
rituximab-pvvr · INJECTION, SOLUTION · Pfizer Laboratories Div Pfizer Inc
Ruxience is a injection, solution containing rituximab-pvvr at 100 mg/10mL, taken intravenous. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Ruxience
- Generic Name
- rituximab-pvvr
- NDC Code (Product)
0069-0238- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 100 mg/10mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761103
- Drug Class
- CD20-directed Cytolytic Antibody [EPC]
- Marketing Start
- 01/23/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Ruxience used for?
Ruxience contains rituximab-pvvr. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Ruxience a controlled substance?
Ruxience is not classified as a controlled substance by the DEA.
What is the generic name for Ruxience?
The generic name for Ruxience is rituximab-pvvr. There are no other listed brand versions of rituximab-pvvr.
What is the NDC code for Ruxience 100 mg/10mL?
The NDC (National Drug Code) for Ruxience 100 mg/10mL is 0069-0238, listed by Pfizer Laboratories Div Pfizer Inc.
Other Ruxience Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)